44
Department of Orthopaedics Polytechnic University of Marche Ancona - Italy A. Gigante The role of Regenerative Medicine

The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Department of Orthopaedics

Polytechnic University of Marche

Ancona - Italy

A. Gigante

The role of Regenerative Medicine

Page 2: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• Articular environment (patient – pathology – grade – side/size)

• Scaffolds

• Cells

TISSUE ENGINEERING

Page 3: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• Biological environment (patient – pathology – grade – side/size)

• Scaffolds

• Cells

TISSUE ENGINEERING

Page 4: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

* Natural polymers

SCAFFOLDS FOR CARTILAGE

• Hydrogels (agarose - alginate) Wang et al., 2007

• Chitosans Muzzarelli et al., 1995

• Synthetic materials (PLA - PGA – PDS)

• Human cartilaginous matrix

• Hyaluronic acid* Pavesio et al., 2003

• Collagen types I and II* Gigante et al., 2003

• Collagen I* + Hydroxyapatite Roveri et al., 1998

• Polysaccharides* (CS photocrosslinkable) Li et al., 2004

• Fibrin gel* Homminga et al., 1993

Page 5: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Biomimicry

BIOMATERIALS PROPERTIES

Page 6: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

CELLS SCAFFOLD

BIOMIMIC SCAFFOLDS

• Collagen I membranes for tendon repair: effect of collagen fiber orientation on cell behavior. Gigante A et al. J Orthop Res. 2009 Jun; 27(6):826-32.

• Adult mesenchymal stem cells for bone and cartilage engineering: effect of scaffold materials. Gigante A et al. Eur J Histochem. 2008; 52(3):169-74.

• Engineered articular cartilage: influence of the scaffold on cell phenotype and proliferation. Gigante A et al. J Mater Sci Mater Med. 2003 Aug;14(8):713-6.

Page 7: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

CARTILAGE EXTRACELLULAR MATRIX

Page 8: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

COLLAGEN

Page 9: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• Chondrocytes in suspension covered by a

membrane (II generation);

• Chondrocytes grown on biological or artificial

scaffolds (MACI – III generation);

• Microfracture covered by a membrane

(AMIC);

• MSCs or buffy coat seeded in a biological or

artificial scaffolds.

SCAFFOLDS

Page 10: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• invasiveness

(mini-open approach or

arthroscopic method)

• operative time

• patient discomfort

Chondrocytes – microfractures – MSCs

grown on biological or artificial scaffolds

Page 11: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

COLLAGEN AS SCAFFOLD

CELLS

CELLS FROM MICROFRACTURES

MESENCHIMAL STEM CELLS (buffy coat)

DIFFERENTIATED CHONDROCYTES

TWO STEPS

ONE STEPS

Page 12: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

MACI® & NOVOCART® 3D

Page 13: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

MACI type I, III collagen (porcine)

Safranin O S-100

protein

Cell density 106

mln/cm2

Gigante et al., 2006

Page 14: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Not controlled, prospective study,

mono and multicentric data

Clinical experience

D’Anchise R., Manta N., Prospero E., Bevilacqua C., Gigante A.

Autologous implantation of chondrocytes on a solid collagen scaffold after two years of follow up.

J Orthopaed Traumatol 6: 36-43, 2005.

Cherubino P., Grassi F.A., Bulgheroni P., Ronga M.

Autologous chondrocyte implantation using a bilayer collagen membrane: a preliminary report.

J Orthop Surg., 11(1): 10-5, 2003

Page 15: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• 59 consecutive cases (10 ♂ - 5 ♀)

• Median age 31

• Follow up 3-5 years

• 51 isolated – 8 multiple lesions

• 33 trauma and microtrauma

• 9 OCD

• 8 degenerative

• 0 connective disease

Patients and methods

Page 16: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Indications

Knee

2 cm2 – max 8 cm2 - mean 4 cm2

Ankle

1 cm2 – max 4 cm2 - mean 2 cm2

33 trauma and microtrauma - 9 OCD

8 degenerative – 0 connective disease

Patients and methods

Page 17: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Associated treatment:

• 9 ACL reconstructions

• 7 valgus osteotomies

• 9 p.f. distal realignments

Patients and methods

Distal realignment and patellar ACI: mid term results in a

selected population.

Gigante A, Enea D, Greco F,

Bait C, Denti M, Schonhuber H, Volpi P

Knee Surg Sports Traum Arthr 2009 ; 17:2-10

Page 18: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Isolated lesions

Page 19: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Multiple lesions

Page 20: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Degenerative lesions: “unshouldered lesions”

• MACI + tissucol + polar sutures

Patients and methods

Page 21: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

14 MACI:

Grading III-IV Outerbridge

Size > 2cm2

Causes:

» 7 malallineaments

» 5 trauma

» 2 doc

Patella and throclea

Page 22: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Glued + sutured membrane Patella

Page 23: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Glued + sutured membrane

Patella

Page 24: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Patella: Glued + sutured membrane + TTT

Distal realignment and patellar ACI: mid term results in a selected population.

Gigante A, Enea D, Greco F, Bait C, Denti M, Schonhuber H, Volpi P

Knee Surg Sports Traum Arthr 2009 ; 17:2-10

Page 25: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Knee: maci by arthroscopy

Arthroscopic Delivery of Matrix-Induced Autologous Chondrocyte Implantation:

International Experience and Technique Recommendations

F. Cortese, M. McNicholas, G. Janes, S. Gillogly, S.P. Abelow, A. Gigante, N. Coletti

Cartilage, 2011, in press

Page 26: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

6 ankle (talus) Gigante et al., JBJS, 2005

ANKLE Ankle: maci by arthroscopy

Page 27: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• Subjective knee function state

VAS (1,2,3,6,12 and 24 M)

• Objective finding:

1. ICRS-surgeon form part

(1: normal; 2: nearly normal;

3: abnormal; 4: severely abnormal)

2. Lysholm and Tegner scores at

baseline and after 6, 12 and 24 months

Materials and methods

“Modified ICRS score”

Page 28: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

TIME

(MONTHS)

0 1 6 12 24 36

N PATIENT/

KNEE 5,42

±1,5

2,71

±1,4

1,03

±1,5

0,45

±0,8

0,21

±0,4

0,23

±0,4

VAS

FUNCTIONAL STATE

TIME

(MONTHS)

0 1 6 12 24 36

2.55±0.

51

* 1.12±0.

31

1.06±0.

27

1.00±0.

25

1.03±0.

25

00:00

01:12

02:24

03:36

04:48

06:00

preop. 6 months 24 months

VAS

Function

Clinical Results at 3 years

Page 29: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

IKDC SCORE (from ICRS score)

TIME (MONTHS) 0 6 12 24 36

Functional

test

3.23

±0.45

1.04

±0.39

1.28

±0.37

1.00

±0.25

1.00

±0.02

Ligament

examination

1.17

±0.34

1.05

±0.27

1.07

±0.28

1.06

±0.28

1.06

±0.58

Passive

motion Deficit

1.06

±0.29

1.03

±0.23

1.00

±0.25

1.00

±0.25

1.00

±0.36

Effusion/

compartment

s findings

2.25

±0.49

1.26

±0.36

1.16

±0.33

1.04

±0.27

1.04

±0.17

Page 30: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Jamshidi needle mm. 3 Ø deep > 5 mm

2nd look and biopsy

• 12 - 24 months

• 22 cases fron multicentric national study

Page 31: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

2nd look and biopsy at 12 months

MACI at medial condyle and ACL reconstruction

Page 32: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Feature/score 0 1 2 3

I. Surface Discontinuities/

irregularities

Smooth/

continuous

II. Matrix Fibrous tissue Fibrocartilage Misture:

hyaline/fibro

cartilage

Hyaline

III. Cell distribution Individual

cells/disorga

nized

Clusters Mixed/columnar-

clusters

Columnar

IV. Cell population

viability

<10% viable Partially viable Predominantly

viable

V. Subchondral Bone Detached/fractur

e/callus at

base

Bone

necrosis

Increased

remodelling

Normal

VI. Cartilage

mineralization

Abnormal/inappr

opriate

location

Normal

ICRS Visual Histological Assessment Scale

Page 33: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Membrane completely reabsorbed at 12 months

Page 34: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

ICRS Visual Histological Assessment Scale

Page 35: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Feature/score 0 1 2 3

V. Subchondral Bone Detached/fractu

re/callus at base

Bone

necrosis

Increased

remodelling

Normal

VI. Cartilage

mineralization

Abnormal/inappr

opriate location

Normal

ICRS Visual Histological Assessment Scale

19/22

Page 36: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

The histological data have confirmed that the regenerated cartilage is a typical hyaline cartilage, with a straight tide-mark with subchondral bone, well-organized cell-clusters and strong reactivity for hyaline markers.

MACI: conclusions

Page 37: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

The cost efficiency

of this technique

remains to be evaluated

Page 38: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

COLLAGEN AS SCAFFOLD

CELLS

CELLS FROM MICROFRACTURES

MESENCHIMAL STEM CELLS (buffy coat)

DIFFERENTIATED CHONDROCYTES

TWO STEPS

ONE STEPS

Page 39: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Cells from buffy coat + collagen membrane

ONE STEP

Page 40: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

MERG

membrana per riparazione guidata

• autologous

• lower costs

• one step

• multi-potent?

ONE STEP

Page 41: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Buffy coat (marrow cells) + Collagen scaffold (MERG)

7 biopsies > 1 year

Gigante A. and Calcagno S.

Page 42: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

MERG 7 biopsies > 1 year

Gigante A., Calcagno S., Cecconi S., Ramazzotti D., Manzotti S., Enea D.

Use of collagen scaffold and bone marow concentrate as a one step cartilage repair in the knee.

Int. J. Immunopathol. Pharmacol., 24 (suppl.2), 69-72, 2011

Page 43: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

• Articular environment (patient – pathology – grade – side/size)

• Scaffolds

• Cells

TISSUE ENGINEERING

Page 44: The role of Regenerative Medicine · • MSCs or buffy coat seeded in a biological or artificial scaffolds. SCAFFOLDS • invasiveness (mini-open approach or arthroscopic method)

Thanks